GRAMD1B and myeloid sarcoma: To assess whether GRAMD1B protein expression can be modulated by inflammatory stimuli, mimicking what happens in MS, human astrocytes were either left untreated (control) or activated with lipopolysaccharides (LPS) and interferon γ (IFNγ).